You are here: Home News Tell the FDA: NO Frankenfish!

Tell the FDA: NO Frankenfish!

The first genetically engineered salmon - dubbed "frankenfish" - could be in grocery stores and restaurants as early as 2014. The FDA is expected to approve AquaBounty Technologies' GE salmon after a 60-day public comment period. If approved, it will be the first approved food from a transgenic animal application to enter the U.S. food supply. Consumer and environmental activists oppose genetically engineered "frankenfish" for many reasons, including the potential danger it poses to human health, to the environment and to the U.S. fishing economy. Michael Hansen, PhD, senior scientist with the Consumers Union, the advocacy and policy arm of Consumer Reports, called the FDA's Environmental Assessment (EA) of GE salmon "flawed and inadequate." Please sign the petition (at the bottom of the page) if you agree that the FDA should reject should AquaBounty's genetically engineered salmon, at least until it completes further, more reliable safety testing.

The first genetically engineered salmon - dubbed "frankenfish" - could be in grocery stores and restaurants as early as 2014. The FDA is expected to approve AquaBounty Technologies' GE salmon after a 60-day public comment period. If approved, it will be the first approved food from a transgenic animal application to enter the U.S. food supply.

Consumer and environmental activists oppose genetically engineered "frankenfish" for many reasons, including the potential danger it poses to human health, to the environment and to the U.S. fishing economy. Michael Hansen, PhD, senior scientist with the Consumers Union, the advocacy and policy arm of Consumer Reports, called the FDA's Environmental Assessment (EA) of GE salmon "flawed and inadequate."

Please sign the petition (at the bottom of the page) if you agree that the FDA should reject should AquaBounty's genetically engineered salmon, at least until it completes further, more reliable safety testing.

What is frankenfish?
AquaBounty Technologies, a Massachusetts-based biotech company, created the "AquAdvantage" salmon by injecting a fragment of DNA from an ocean pout fish, which is a type of eel, along with a growth hormone gene from the Chinook Pacific salmon, into a fertilised Atlantic salmon egg. The result? A salmon that produces growth hormone year round, instead of only during warm weather. This allows the fish to reach market weight in just 18 months, instead of the usual three years.

What are the risks?
  1. Potential harm to human health. The FDA has allowed this fish to move forward based on tests of allergenicity of only six GE fish. Even with such limited testing, the results showed an increase in allergy-causing potential, according to Hansen. AquAdvantage also contains elevated levels of the growth hormone, IGF-1, which is linked to prostate, breast and colon cancers.
  2. Potential harm to wild salmon population. Only 95% of the AquAdvantage salmon may be sterile, the rest fertile. Plus, the fish at the egg production facility in Prince Edward Island, Canada, will not be sterile. The FDA says the likelihood of the GE salmon escaping into the wild is "extremely remote" but gave little reassuring evidence to support that assumption. According to studies, the frankenfish eat five times more food than wild salmon, and have less fear of predators. All it would take is for some of these frankenfish to escape, and the world's wild salmon population would be at risk.
  3. Unlabeled. Without GMO labeling, consumers will not be able to avoid frankenfish when it arrives in grocery stores and fish markets.
  4. Less nutritious. GE salmon contains less Omega-3 fatty acids than non-GE salmon. Omega-3 fatty acids are the "good" fat which has important health benefits.

Read the full article and take action...

powered by Plone | site by Groundwire Consulting and served with clean energy